"CDKN2A" Related Products

Expand
Expand
Expand

Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A

Cat. No.: CDKN2A-10H
Product Overview: Recombinant Human Cyclin-Dependent Kinase Inhibitor 2A produced inE.coliis a single non-glycosylated polypeptide chain containing 156 amino acids and having a molecular mass of approximately 16.5 kDa.
Description: Cyclin-dependent kinase inhibitors (CDKIs) are proteins that bind to and inhibit the activity of CDKs. Two major classes of CDK inhibitors have been identified. The p16 family (p15, p16, p18 and p19) binds to and inhibits the activities of CDK4 and CDK6. The p21 family (p21, p27, p28 and p57) can bind to broad range of CDK-cyclin complexes and inhibit their activities. CDKIs are capable of suppressing growth, and several lines of evidence strongly suggest that at least some CDKIs may be tumor suppressor proteins.
Purity: >95% by SDS-PAGE and HPLC analyses.
Formulation: Lyophilized from a 0.2μm filtered concentrated (1mg/ml) solution in 1×PBS,pH 7.4.
Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.
Endotoxin: Less than 1EU/μg of rHuP16 as determined by LAL method.
Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportioned into working aliquots and stored at <-20°C. Further dilutions should be made in appropriate buffered solutions.
Storage: This lyophilized preparation is stable for several weeks at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.
Gene Name: CDKN2A
Synonyms: ARF; MLM; p14; p16; p19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4a; p14ARF; p16INK4; p16INK4a; cyclin-dependent kinase inhibitor2A(melanoma, p16, inhibits CDK4); CD2A2_HUMAN; Cyclin-dependent kinase inhibitor2A, isoform 4; p19ARF; MTS-1; p16-INK4; p16-INK4a; CDK4 inhibitor p16-INK4; Cyclin-dependent kinase 4 inhibitor A; Cyclin-dependent kinase inhibitor2A, isoforms1/2/3; Multiple tumor suppressor 1; cell cycle negative regulator beta;cyclin-dependent kinase inhibitor2A; cyclin-dependent kinase inhibitor p16; CDKN2A
Gene ID: 1029
mRNA Refseq: NM_000077
Protein Refseq: NP_000068
MIM: 600160
UniProt ID: P42771
Chromosome Location: 9p21
Pathway: Cell cycle; Chronic myeloid leukemia;Glioma;Melanoma;Non-small cell lung cancer;Pancreatic cancer.
Function: DNA binding;NF-kappaB binding;cyclin-dependent protein kinase inhibitor activit y;protein binding;protein kinase binding; ubiquitin-protein ligase inhibitor activity

Online Inquiry

Note: There will be extra charge for optional service!
Optional requirements on this protein    +Expand
C-fusion    N-fusion   Non-tagged
His    GST   Fc   Others
<1.0 eu/μg    <0.1 eu/μg   <0.01 eu/μg   Not required
Monomer Isolation    Dimer Isolation    Not required
>80% by SDS-PAGE    >90% by SDS-PAGE   >95% by SDS-PAGE   Others

Please input "biomart" as verification code. Please review Creative BioMart's privacy policy for more information


Price does not include shipping and packaging costs.Request quote for final price.

Price Inquiry

Welcome! For price inquiries, please feel free to contact us through the form below. We will get back to you as soon as possible.